Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kestra Medical TechnologiesKMTS -0.42%12 Future 3-5Y EPS without NRI Growth Rate is 11.37 as of Sep. 11, 2026. GuruFocus rates KMTS with a GF Score™ of 12/100. The stock has 5 warning signs investors should review. Among 284 Medical Devices & Instruments companies, Kestra Medical Technologies ranks worse than 75.7% on this metric.
Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Kestra Medical Technologies (NAS:KMTS) Future 3-5Y EPS without NRI Growth Rate Explanation
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
Kestra Medical Technologies Future 3-5Y EPS without NRI Growth Rate Related Terms
KMTS vs AZTA, BLFS, LMAT: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Kestra Medical Technologies's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kestra Medical Technologies Future 3-5Y EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kestra Medical Technologies's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Kestra Medical Technologies's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 11.37 mean?
Kestra Medical Technologies (KMTS) has a Future 3-5Y EPS without NRI Growth Rate of 11.37 as of Sep. 11, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Kestra Medical Technologies and its competitors. According to the industry distribution chart, Kestra Medical Technologies ranks #215 out of 284 companies in the Medical Devices & Instruments industry, placing it in the top 75.7%.
Is Kestra Medical Technologies' Future 3-5Y EPS without NRI Growth Rate too high?
Kestra Medical Technologies' current Future 3-5Y EPS without NRI Growth Rate is 11.37. The Medical Devices & Instruments industry median Future 3-5Y EPS without NRI Growth Rate is 20.78. Kestra Medical Technologies' value of 11.37 is 45.3% below this industry median. Based on the distribution chart, Kestra Medical Technologies ranks #215 out of 284 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Kestra Medical Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Kestra Medical Technologies' Future 3-5Y EPS without NRI Growth Rate compare to AZTA and BLFS?
According to the Medical Devices & Instruments industry distribution chart, Kestra Medical Technologies ranks #215 out of 284 companies for Future 3-5Y EPS without NRI Growth Rate. This places Kestra Medical Technologies in the lower half of its industry. The industry median Future 3-5Y EPS without NRI Growth Rate is 20.78. Kestra Medical Technologies' value of 11.37 is 45.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median Future 3-5Y EPS without NRI Growth Rate among Medical Devices & Instruments companies is 20.78, based on 284 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kestra Medical Technologies's current Future 3-5Y EPS without NRI Growth Rate of 11.37 is 45.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Kestra Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Future 3-5Y EPS without NRI Growth Rate is 20.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kestra Medical Technologies's current Future 3-5Y EPS without NRI Growth Rate is 11.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kestra Medical Technologies stock overvalued right now?
Kestra Medical Technologies (KMTS) has a current Future 3-5Y EPS without NRI Growth Rate of 11.37. The current Future 3-5Y EPS without NRI Growth Rate is 11.37 and 45.3% below the Medical Devices & Instruments industry median of 20.78. Kestra Medical Technologies' overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For Kestra Medical Technologies (KMTS), the current Future 3-5Y EPS without NRI Growth Rate is 11.37 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
12GF Score
Get the complete analysis for KMTS
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KMTS has been successfully added to your 
